Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas

NCT01668095 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01668095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01668095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult rhabdomyosarcoma, childhood alveolar rhabdomyosarcoma, childhood embryonal rhabdomyosarcoma, previously treated childhood rhabdomyosarcoma, recurrent adult soft tissue sarcoma, recurrent childhood rhabdomyosarcoma, stage iii adult soft tissue sarcoma, stage iv adult soft tissue sarcoma